Skip to main content

Affording Treatment

Diabetes care can be expensive, from daily supplies to glucose monitoring technology to medications to clinical care visits. The good news is there are a number of ways to afford treatment when living with diabetes, whether you are navigating a health insurance plan or paying out of pocket.

We bring you tips on saving money, navigating private insurance, workplace benefits, and Medicare, in addition to information about discounts on the drugs and devices that you use.

What's new

You may have heard about Semglee and Rezvoglar, popular alternatives for Lantus insulin; these are “biosimilars.” But what is a biosimilar? How is it different from a generic drug? Find answers to these questions and some tips on how to discuss biosimilars with your healthcare provider. Continue Reading »

Patient with Professional CGM

CGMs provide information that you can use to improve your blood glucose. If you don't currently use a CGM, your healthcare team can offer you a “professional” CGM to use for a week or two so that you can see how to increase your Time in Range. Read more about what a professional CGM is and if it could be right for you. Continue Reading »

One Drop diabetes and blood pressure programs

An evaluation from an independent, third-party found that One Drop’s multi-condition support program effectively improves the health of people living with prediabetes, diabetes, and high blood pressure. The program could also cut down on annual healthcare costs.  Continue Reading »

Civica, a nonprofit pharmaceutical company, announced plans to make generic insulin available for $30 per vial or $55 for five prefilled pens, regardless of insurance status. Continue Reading »

US pharmaceutical companies and insulin manufacturers react to proposed legislation that would cap insulin costs and prevent significant rises in the costs of prescription drugs. Continue Reading »

clinical trial for diabetes treatment

Clinical trials are the middle step between scientific discoveries in the lab and making these discoveries available to the public. Learn how clinical trials work, the experience of participating, and how you can get involved. Continue Reading »

Lilly’s new basal insulin, Rezvoglar, may provide a cheaper alternative to Lantus. This marks the second approval of a biosimilar long-acting insulin. Continue Reading »

As we approach the new year, we want to remind you that if you've met your annual health insurance deductible or are close to meeting it, do not forget to order any diabetes supplies you need before your deductible resets on January 1 (in the US). Continue Reading »

Pages